Published in Nat Rev Nephrol on April 01, 2009
Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum (2012) 1.32
Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis. Arthritis Res Ther (2011) 0.93
Understanding lupus nephritis: diagnosis, management, and treatment options. Int J Womens Health (2012) 0.85
The development of membranous lupus nephritis during treatment with mycophenolate mofetil for proliferative renal disease. NDT Plus (2010) 0.82
Towards new avenues in the management of lupus glomerulonephritis. Nat Rev Rheumatol (2016) 0.79
Immunoadsorption: a new strategy to induce remission in membranous lupus nephritis. Case Rep Nephrol Urol (2014) 0.78
Clinicopathological insights into lupus glomerulonephritis in Japanese and Asians. Clin Exp Nephrol (2011) 0.78
Chapter 12: Lupus nephritis. Kidney Int Suppl (2011) (2012) 0.75
Rituximab alone as induction therapy for membranous lupus nephritis: A multicenter retrospective study. Medicine (Baltimore) (2017) 0.75
[Renal emergencies in cases of collagenosis and vasculitis]. Z Rheumatol (2012) 0.75
Membranous nephropathy-one morphologic pattern with different diseases. Pflugers Arch (2017) 0.75
Redefining lupus nephritis: clinical implications of pathophysiologic subtypes. Nat Rev Nephrol (2017) 0.75
[Renal diseases in rheumatology]. Z Rheumatol (2013) 0.75
Immunosuppressive treatment for pure membranous lupus nephropathy in a Hispanic population. Clin Rheumatol (2016) 0.75
The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol (2004) 7.38
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med (2005) 6.83
Sequential therapies for proliferative lupus nephritis. N Engl J Med (2004) 5.96
Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med (2003) 4.58
Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial. Kidney Int (2007) 3.52
Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network. Kidney Int (1997) 2.25
Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis. Arthritis Rheum (2007) 1.87
Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus (2002) 1.85
B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients. Rheumatology (Oxford) (2005) 1.83
Renal involvement in systemic lupud erythematosus (SLE): a study of 56 patients emphasizing histologic classification. Medicine (Baltimore) (1978) 1.57
Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study. Arthritis Rheum (2004) 1.51
Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up. Nephrol Dial Transplant (2006) 1.46
Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization. Am J Med (1987) 1.42
Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups. Arthritis Rheum (2005) 1.41
Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center. Medicine (Baltimore) (1999) 1.39
Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis. Arthritis Rheum (2004) 1.27
Prognostic determinants in lupus nephritis: a long-term clinicopathologic study. Lupus (1995) 1.24
Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Arthritis Rheum (1998) 1.22
Current treatment of lupus nephritis. Lupus (2008) 1.20
Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study. Kidney Int (2005) 1.18
The very long-term prognosis and complications of lupus nephritis and its treatment. QJM (1999) 1.14
Renal biopsy in lupus patients with low levels of proteinuria. J Rheumatol (2006) 1.07
Lupus nephritis: clinical and pathological correlation. Q J Med (1987) 1.02
Causes and predictors of death in South Africans with systemic lupus erythematosus. Rheumatology (Oxford) (2007) 1.01
A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease. J Rheumatol (1999) 1.00
Incidence and predictors of renal disease in Chinese patients with systemic lupus erythematosus. Am J Med (2004) 0.99
Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice. Nephrol Dial Transplant (2008) 0.98
Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis. Lupus Nephritis Collaborative Study Group. J Am Soc Nephrol (1996) 0.98
Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide. Am J Med (2006) 0.98
Mycophenolate therapy of SLE membranous nephropathy. Kidney Int (2004) 0.97
Effect of pravastatin on proteinuria in patients with well-controlled hypertension. Hypertension (2002) 0.95
Lupus nephritis: prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). Am J Kidney Dis (1992) 0.93
Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression. Lupus (1999) 0.93
A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade. Lupus (2007) 0.92
Outcome of silent lupus nephritis. Semin Arthritis Rheum (1996) 0.92
Lupus membranous nephropathy: long-term outcome. Clin Nephrol (1993) 0.91
Lupus in the 1980s: III. Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single center. Semin Arthritis Rheum (1995) 0.91
Lupus nephritis in children--a review of 167 patients. Pediatrics (1994) 0.91
Lupus nephritis in Southern Chinese patients: clinicopathologic findings and long-term outcome. Am J Kidney Dis (1999) 0.90
Factors affecting outcome and prognosis in membranous lupus nephropathy. Nephrol Dial Transplant (2002) 0.89
Membranous lupus nephropathy: a clinicopathologic study. Medicine (Baltimore) (1977) 0.89
Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases. Lupus (2008) 0.88
Clinical and pathological features of membranous glomerulonephritis of systemic lupus erythematosus. Am J Nephrol (1984) 0.88
Lupus nephritis: treatment with mycophenolate mofetil. Rheumatology (Oxford) (2004) 0.88
Cyclosporine treatment of lupus membranous nephropathy. Clin Nephrol (1994) 0.88
Prevention of murine lupus disease in (NZBxNZW)F1 mice by sirolimus treatment. Lupus (2007) 0.87
Treatment of pure membranous lupus nephropathy with prednisone and azathioprine: an open-label trial. Am J Kidney Dis (2004) 0.86
Long-term outcome of Chinese patients with membranous lupus nephropathy. Lupus (2008) 0.86
Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review. Scand J Rheumatol (2007) 0.85
Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy. Rheumatology (Oxford) (2005) 0.83
A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy. Clin Nephrol (1999) 0.83
Cyclosporine for lupus membranous nephritis: experience with ten patients and review of the literature. Lupus (2000) 0.82
Membranous glomerulopathy in systemic lupus erythematosus. Adv Nephrol Necker Hosp (1985) 0.81
Good response of membranous lupus nephritis to tacrolimus. Clin Nephrol (2006) 0.81
Risk and predictors of arterial thrombosis in lupus and non-lupus primary glomerulonephritis: a comparative study. Medicine (Baltimore) (2007) 0.80
Treatment of membranous lupus nephritis. Am J Kidney Dis (1998) 0.80
Lupus membranous glomerulonephritis: different prognostic subgroups obscured by imprecise histologic classifications. Mod Pathol (1990) 0.80
Mycophenolate mofetil in lupus glomerulonephritis. Am J Kidney Dis (2002) 0.80
Severe bone marrow failure associated with the use of alternating steroid with chlorambucil in lupus membranous nephropathy in Chinese. Lupus (2001) 0.79
Cyclosporine A in treatment of membranous lupus nephropathy. Chin Med J (Engl) (2003) 0.79
Membranous nephropathy: when and how to treat. Kidney Int (2007) 0.79
Clinical presentation and outcome in a cohort of paediatric patients with membranous lupus nephritis. Nephrol Dial Transplant (2007) 0.79
Nonimmunosuppressive therapy of membranous nephropathy. Semin Nephrol (2003) 0.78